๐Ÿ“–
Current drug design to target the Semaphorin/Neuropilin/Plexin complexes
Lionel Meyer, Justine Fritz, Marie Pierdant, Dominique Bagnard

Current drug design to target the Semaphorin/Neuropilin/Plexin complexes

Science & Mathematics Published 2016 Verification Pending

Overview & Synopsis

The Semaphorin/Neuropilin/Plexin (SNP) complexes control a wide range of biological processes. Consistently, activity deregulation of these complexes is associated with many diseases. The increasing knowledge on SNP had in turn validated these molecular complexes as novel therapeutic targets. Targeting SNP activities by small molecules, antibodies and peptides or by soluble semaphorins have been proposed as new therapeutic approach. This review is focusing on the latest demonstration of this potential and discusses some of the key questions that need to be addressed before translating SNP targeting into clinically relevant approaches.

Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Current drug design to target the Semaphorin/Neuropilin/Plexin complexes
Author / Organization Lionel Meyer, Justine Fritz, Marie Pierdant, Dominique Bagnard
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2016
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-251811
Original Source Link Visit Source Page on hal.science »